Literature DB >> 8619090

Epidemiology of rheumatoid arthritis.

G S Alarcón1.   

Abstract

Rheumatoid arthritis is a relatively common disorder that affects men and women at the prime of their lives. Only 30% of the causes of rheumatoid arthritis can be attributed to genetic factors; the rest remain unexplained. Descriptive and analytic epidemiologic methods may lead to a better understanding of the causative, precipitating, and modulatory factors in rheumatoid arthritis.

Entities:  

Mesh：

Year:  1995        PMID： 8619090

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  23 in total

1.  Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats.

Authors:  Venkatesan Saratha; Sorimuthu Pillai Subramanian
Journal:  Inflammopharmacology       Date:  2011-10-16       Impact factor: 4.473

Review 2.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

4.  Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group.

Authors:  Andrea Klauser; Johannes Demharter; Armanda De Marchi; Delia Sureda; Antonio Barile; Carlo Masciocchi; Carlo Faletti; Michael Schirmer; Timm Kleffel; Klaus Bohndorf
Journal:  Eur Radiol       Date:  2005-08-16       Impact factor: 5.315

Review 5.  Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. A review.

Authors:  M B Nichol; A S Harada
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

6.  Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.

Authors:  César Díaz-Torné; M Angels Ortiz de Juana; Carme Geli; Elisabet Cantó; Ana Laiz; Héctor Corominas; Jordi Casademont; Josep M de Llobet; Cándido Juárez; César Díaz-López; Sílvia Vidal
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

7.  Promising clinical results of the universal total wrist prosthesis in rheumatoid arthritis.

Authors:  P J T S van Winterswijk; P A G M Bakx
Journal:  Open Orthop J       Date:  2010-02-17

8.  Synovial tissue hypoxia and inflammation in vivo.

Authors:  C T Ng; M Biniecka; A Kennedy; J McCormick; O Fitzgerald; B Bresnihan; D Buggy; C T Taylor; J O'Sullivan; U Fearon; D J Veale
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

9.  Detection of vascularity in wrist tenosynovitis: power doppler ultrasound compared with contrast-enhanced grey-scale ultrasound.

Authors:  Andrea S Klauser; Magdalena Franz; Rohit Arora; Gudrun M Feuchtner; Johann Gruber; Michael Schirmer; Werner R Jaschke; Markus F Gabl
Journal:  Arthritis Res Ther       Date:  2010-11-09       Impact factor: 5.156

10.  Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database.

Authors:  Onur Baser; Abdulkadir Burkan; Erdem Baser; Rasim Koselerli; Emre Ertugay; Akif Altinbas
Journal:  Rheumatol Int       Date:  2013-05-25       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.